Patents Examined by Aaron J Kosar
  • Patent number: 11911431
    Abstract: The present disclosure relates to compositions and methods for helping to manage the lingering symptoms and effects of COVID-19 after recovery. Specifically, the present disclosure relates to sustained release dietary and nutritional supplement compositions and methods to provide ongoing support and symptom management for individuals exposed to SARS-CoV-2 who contacted COVID-19 and later recovered but continue to experience after-effects or lingering symptoms. Specifically, the composition is based on a sustained release ashwagandha extract, alone in a therapeutically effective amount, or in combination with other ingredients.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: February 27, 2024
    Assignee: Arjuna Natural PVT LTD.
    Inventor: Michael Lelah
  • Patent number: 11911433
    Abstract: A preparation method of non-ester tea polyphenols rich in EGC. Includes leaching wall-broken crushed tea leaves using endogenous hydrolytic enzymes contained in the tea leaves; refining the leached solution after filtration and concentration and purifying it by mobile leaching-water washing; concentrating and drying the purified product to obtain a non-ester tea polyphenols product rich in EGC, wherein the content of tea polyphenols is 90-99.5%, the content of EGC is greater than 80%, and the content of ester catechins EGCG+ECG is less than 10%.
    Type: Grant
    Filed: January 17, 2022
    Date of Patent: February 27, 2024
    Assignee: JIANGSU DEHE BIOTECHNOLOGY CO., LTD.
    Inventors: Xueyin Ren, Jianhong Liu, Houjian Cao, Pingnan Pu, Dehe Liu
  • Patent number: 11913860
    Abstract: A method of removing a floatation liquid from between a microscope slide and a paraffin embedded biological specimen including position the microscope slide with the paraffin embedded biological specimen floated thereon onto a slide support element. The slide support element is rotated to cause the microscope slide and the paraffin embedded biological specimen to move in a way that causes the floatation liquid disposed between the microscope slide and the paraffin embedded biological specimen to be removed from between the microscope slide and the paraffin embedded biological specimen.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: February 27, 2024
    Inventor: Lee H Angros
  • Patent number: 11904047
    Abstract: An herbal composition includes a plurality of herbal components designed to work harmoniously together to alleviate pain and reduce inflammation of the oral mucosa. Such pain and inflammation may be associated with, for example, recurrent aphthous stomatitis. The formulation can include ginger, cayenne, cloves, cinnamon, turmeric, and annatto. The herbal composition may be formulated as a candy or gum, for example, to provide effective delivery to the oral mucosa.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: February 20, 2024
    Inventors: Sandie Tran, Sang Nguyen
  • Patent number: 11903988
    Abstract: A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.
    Type: Grant
    Filed: February 11, 2022
    Date of Patent: February 20, 2024
    Inventor: Krishna Rajendran
  • Patent number: 11904043
    Abstract: Compositions, methods, and kits for cleansing, moisturizing, soothing, cooling, such as those, for example, that may be used to cleanse, moisturize, soothe, and cool the body or portions thereof.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: February 20, 2024
    Inventors: Brandon Joseph Karam, Jessica Karam Oley
  • Patent number: 11896624
    Abstract: A composition for decreasing proliferation of cancer cells undergoing hyperthermia therapy is described. Such compositions can include a combination of selenium and fish oil. The respective quantities of selenium and fish oil are provided in amounts effective to synergistically increase the sensitivity of the cancer cells to temperatures in excess of 37° C.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: February 13, 2024
    Inventor: Houn Simon Hsia
  • Patent number: 11884721
    Abstract: Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immunotolerance may be created by use of the fusions and choice of an antigen on a substance for which tolerance is desired. Fusions with targeting peptides direct the fusions to the target, for instance a tumor, where the erythrocyte-binding ligands reduce or entirely eliminate blood flow to the tumor by recruiting erythrocytes to the target.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: January 30, 2024
    Assignee: École Polytechnique Fédérale de Lausanne (EPFL)
    Inventors: Jeffrey A. Hubbell, Stephan Kontos, Karen Y. Dane
  • Patent number: 11872201
    Abstract: There is provided a vegetable-based lipid composition comprising very high levels of DHA, together with at least one other long-chain polyunsaturated fatty acid (typically as fatty acid esters). The composition typically contains low levels of EPA and palmitic acid. The composition is obtainable from a single source by conventional processing methods, and has improved stability properties.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: January 16, 2024
    Assignee: Nuseed Nutritional US Inc.
    Inventor: Stuart Littler
  • Patent number: 11872258
    Abstract: Embodiments of the invention include a system having a plant stem cell product and a delivery device configured to deliver an effective amount of the plant stem cell product to the oral cavity or nasopharynx. In some embodiments, the delivery device may include an aerosolizing device, an adherent dressing, a tooth-adherent flexible strip, a treatment tray, a viscous adherent carrier, a brush, a paste, a flosser, a dissolving oral strip, a gum, a chew, a smoking material, a nasal packing, or a lozenge. The plant stem cell products may include encapsulated extracts of plant stem cells, such as food species stem cells, spice or other seasoning stem cells, or medicinal plant stem cells.
    Type: Grant
    Filed: November 24, 2019
    Date of Patent: January 16, 2024
    Assignee: StemStix, Inc.
    Inventor: Maryam Rahimi
  • Patent number: 11873519
    Abstract: A composition and method for reversing or preventing age-related metabolic and tissue degenerative changes in individuals. The method includes administering, orally, an effective amount of a first composition having methioninase enzyme. The method further includes administering, by a route other than the oral route, such as a parenteral route, an effective amount of a second composition having methioninase enzyme. The method further includes the steps of orally and/or parentally administering pyridoxal-L-phosphate.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: January 16, 2024
    Inventors: Qinghong Han, Robert M Hoffman
  • Patent number: 11865155
    Abstract: An extract from leaves of mulberry is disclosed. The extract has an IC50 value sufficient to inhibit a-glucosidase I. The extract may comprise 5-40% (w/w) total imino sugars and 20-70% (w/w) total amino acids. The extract may reduce the production of melanin for the treatment of such ailments or diseases caused by pigmentation as freckle, chloasma, striae gravidarum, sensile plaque and melanoma. The extract may also control blood glucose level.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: January 9, 2024
    Inventors: Chen Xie, Yingshu Zou
  • Patent number: 11864570
    Abstract: The present invention is directed to a therapeutic composition including an active therapeutic ingredient combined with a liquid or solution based carbonated beverage. The invention as described details the use or administration of the therapeutic composition so as to treat a variety of ailments. The present invention is also directed to a method of administering the therapeutic composition to an individual for the purposes of alleviating an ailment. In a further arrangement, the therapeutic composition is provided to a user as a pre-packaged volume containing a single effective dose of the therapeutic agent.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: January 9, 2024
    Assignee: VISION PHARMA, LLC
    Inventor: Sander S. Busman
  • Patent number: 11865131
    Abstract: The present invention relates to a process for producing an extract powder from a fruit material of e.g. berry fruits, wherein anthocyanins are enriched from the fruit material, and to the product obtainable by the process. In the process according to the invention, anthocyanins are enriched via a cation exchanger. By eluting the anthocyanins from the cation exchanger by means of L-arginine, the process has the advantage that no salt needs to be purified from the eluate to produce an extract powder suitable for use as a dietary supplement.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: January 9, 2024
    Assignee: Deutsches Institut für Lebensmitteltechnik e.V.
    Inventor: Andreas Juadjur
  • Patent number: 11857593
    Abstract: A nutraceutical food product includes a solid matrix and a liquid combined into a gel. The nutraceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component may be included in the nutraceutical food product. The fruit component may include at least one oligoproanthocyanidin-containing fruit, such as açai.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: January 2, 2024
    Assignee: 4Life Patents, LLC
    Inventors: Brent M. Vaughan, Calvin W. McCausland, David A. Lisonbee
  • Patent number: 11857667
    Abstract: A method for treating the skin of a subject in need thereof is disclosed. The method includes topically applying to the skin of the subject a cosmetic composition that includes an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract of Silybum marianum and an aqueous, alcoholic, or aqueous-alcoholic extract of Momordica grosvenori fruit.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: January 2, 2024
    Assignee: MARY KAY INC.
    Inventors: Tiffany Florence, Michelle Hines, David Gan
  • Patent number: 11850297
    Abstract: A composition containing a combination of exosomes and sapogenin as an active ingredient is disclosed. The composition is able to promote preadipocyte proliferation, lipid uptake into adipocytes, and/or adipogenesis, but reduce the cytotoxicity caused by sapogenin. Therefore, the composition can reduce side effects on the body or skin, and can be used such that it is conveniently applied to a dissatisfactory part of the body showing flaws which look less plump due to a deficit in lipids and the like, or an area of the skin showing flaws caused by a deficit in lipids.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: December 26, 2023
    Assignee: ExoCoBio Inc.
    Inventors: Yong Weon Yi, Byong Seung Cho
  • Patent number: 11844364
    Abstract: The present invention is directed to a therapeutic composition including an active therapeutic ingredient combined with a liquid or solution based carbonated beverage. The invention as described details the use or administration of the therapeutic composition so as to treat a variety of ailments. The present invention is also directed to a method of administering the therapeutic composition to an individual for the purposes of alleviating an ailment. In a further arrangement, the therapeutic composition is provided to a user as a pre-packaged volume containing a single effective dose of the therapeutic agent.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: December 19, 2023
    Assignee: VISION PHARMA, LLC
    Inventor: Sander S. Busman
  • Patent number: 11844821
    Abstract: Discloses is a single herb extract for the treatment of PCOS (Poly Cystic Ovarian Syndrome) when given in oral dosage form as capsules of 500 mg, twice a day for period of time ranging from 30-90 days. The extract is obtained from fenugreek seeds using a specific method of extraction and comprises five furostanolicsaponins present in synergistic ratios as in Table 1 and having analytical profile as in FIG. 1.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: December 19, 2023
    Inventor: Pawan Kumar Goel
  • Patent number: 11844820
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analogue or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof, and (ii) tannic acid, or an analogue or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: December 19, 2023
    Assignee: ARTHRITIS RELIEF PLUS LTD.
    Inventors: Larry McKay, Kanu Patel, Robert John Capon